Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
22.1M
-
Shares change
-
-850K
-
Total reported value, excl. options
-
$772M
-
Value change
-
-$61.5M
-
Put/Call ratio
-
0.85
-
Number of buys
-
76
-
Number of sells
-
-97
-
Price
-
$34.96
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q1 2020
193 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q1 2020.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.1M shares
of 53M outstanding shares and own 41.63% of the company stock.
Largest 10 shareholders include CAS Investment Partners, LLC (3.95M shares), FMR LLC (1.49M shares), WELLINGTON MANAGEMENT GROUP LLP (1.26M shares), BlackRock Inc. (1.19M shares), VANGUARD GROUP INC (1.07M shares), 683 Capital Management, LLC (867K shares), Grantham, Mayo, Van Otterloo & Co. LLC (808K shares), KPS Global Asset Management UK Ltd (750K shares), Antipodean Advisors LLC (656K shares), and JS Capital Management LLC (544K shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.